The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level
ANNALS OF NUCLEAR MEDICINE, cilt.28, sa.10, ss.970-979, 2014 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 28 Sayı: 10
- Basım Tarihi: 2014
- Doi Numarası: 10.1007/s12149-014-0897-7
- Dergi Adı: ANNALS OF NUCLEAR MEDICINE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.970-979
- Anahtar Kelimeler: FDG-PET/CT, Elevated anti-Tg level, Thyroid cancer, SERUM ANTITHYROGLOBULIN ANTIBODY, ADDITIVE CLINICAL-VALUE, THYROGLOBULIN ANTIBODIES, F-18-FDG PET/CT, GRAVES-DISEASE, RADIOACTIVE IODINE, FOLLOW-UP, CARCINOMA, AUTOANTIBODIES, RECURRENCE
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
In the follow-up of differentiated thyroid cancer (DTC) after a successful total-near total thyroidectomy and I-131 ablation therapy, anti-thyroglobulin antibodies (anti-Tg) may be persistently or progressively increased in the patients with an undetectable serum thyroglobulin (Tg) level. In these cases, further investigation was performed to search for recurrence/metastases. The aim of our study was clarifying the role of FDG-PET/CT in detecting recurrence/metastasis in patients with DTC with negative serum Tg and elevated anti-Tg level.